Corbus shares will soar or dive soon. Here’s why

Senior Writer, Biotech

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard.

Finding the right solution and partner for your drug product’s commercial supply chain – Pharmaceutical Technology

Biomanufacturers should bear a series of critical steps in mind when working out how to get their products to clients worldwide. A vast range of

July 17, 2024

Study reveals impact of smoking elimination on global life expectancy

Accelerating the decline in tobacco smoking globally, by decreasing smoking prevalence from current levels to 5% everywhere, could increase life expectancy and prevent millions of

October 4, 2024

Lack of Institutional Support a Top Reason Why Doctors Hesitate to Treat Addiction

A lack of institutional support topped the list of reasons why clinicians may be reluctant to intervene in addiction, according to a systematic review of

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.